ViewRay, Inc. announced the Czech Ministry of Health has approved the purchase of ViewRay's MRIdian system to bring advanced MRI-guided radiation therapy to treat its cancer patients at the Military University Hospital Prague in the Czech Republic. This is the first and only hospital to offer the precision of MRIdian Stereotactic MRI-guided Adaptive Radiotherapy (SMART) in the Czech Republic. The purchase was co-financed by the REACT-EU financial instrument and the founder's contribution, the Ministry of Defense of the Czech Republic.

The Military University Hospital Prague is a training, educational, and professional medical facility of the Army of the Czech Republic. It provides comprehensive health care at the level of teaching hospitals to members of the Czech Army, war veterans, and people in and outside the region. The hospital has 10 clinics and 20 specialized departments, many collaborating to train medical students in medical schools.

The hospital is equipped with modern technology and reflects contemporary trends in medicine. The MRIdian system provides oncologists with outstanding anatomical visualization through diagnostic-quality MR images and the ability to adapt a radiation therapy plan to the targeted cancer with the patient on the table. This combination allows physicians to define tight treatment margins to avoid unnecessary radiation exposure of vulnerable organs-at-risk and healthy tissue and allows the delivery of ablative radiation doses in five or fewer treatment sessions without relying on implanted markers.

MRIdian enables automatic gating of the radiation beam if the target moves outside the user-defined margins by providing continuous real-time tracking of the target and organs at risk. This allows for delivering the prescribed dose to the target while sparing surrounding healthy tissue and critical structures. This results in minimizing toxicities typically associated with conventional radiation therapy.